Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination.
<h4>Background</h4>The increase in recent outbreaks and unpredictable changes of highly pathogenic avian influenza (HPAI) H5N1 in birds and humans highlights the urgent need to develop a cross-protective H5N1 vaccine. We here report our development of a multiple-clade H5N1 influenza vacc...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/81168c1b49bd4041a4f4db30461827a8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:81168c1b49bd4041a4f4db30461827a8 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:81168c1b49bd4041a4f4db30461827a82021-11-18T07:29:55ZMultiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination.1932-620310.1371/journal.pone.0030252https://doaj.org/article/81168c1b49bd4041a4f4db30461827a82012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22279575/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The increase in recent outbreaks and unpredictable changes of highly pathogenic avian influenza (HPAI) H5N1 in birds and humans highlights the urgent need to develop a cross-protective H5N1 vaccine. We here report our development of a multiple-clade H5N1 influenza vaccine tested for immunogenicity and efficacy to confer cross-protection in an animal model.<h4>Methodology/principal findings</h4>Mice received two doses of influenza split vaccine with oil-in-water emulsion adjuvant SP01 by intranasal administration separated by two weeks. Single vaccines (3 µg HA per dose) included rg-A/Vietnam/1203/2004(Clade 1), rg-A/Indonesia/05/2005(Clade 2.1), and rg-A/Anhui/1/2005(Clade 2.3.4). The trivalent vaccine contained 1 µg HA per dose of each single vaccine. Importantly, complete cross-protection was observed in mice immunized using trivalent vaccine with oil-in-water emulsion adjuvant SP01 that was subsequently challenged with the lethal A/OT/SZ/097/03 influenza strain (Clade 0), whereas only the survival rate was up to 60% in single A/Anhui/1/2005 vaccine group.<h4>Conclusion/significance</h4>Our findings demonstrated that the multiple-clade H5N1 influenza vaccine was able to elicit a cross-protective immune response to heterologous HPAI H5N1 virus, thus giving rise to a broadly cross-reactive vaccine to potential prevention use ahead of the strain-specific pandemic influenza vaccine in the event of an HPAI H5N1 influenza outbreak. Also, the multiple-clade adjuvanted vaccine could be useful in allowing timely initiation of vaccination against unknown pandemic virus.Penghui YangYueqiang DuanPeirui ZhangZhiwei LiCheng WangMei DongChong TangLi XingHongjing GuZhongpeng ZhaoXiufan LiuShaogeng ZhangXiliang WangPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 1, p e30252 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Penghui Yang Yueqiang Duan Peirui Zhang Zhiwei Li Cheng Wang Mei Dong Chong Tang Li Xing Hongjing Gu Zhongpeng Zhao Xiufan Liu Shaogeng Zhang Xiliang Wang Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination. |
description |
<h4>Background</h4>The increase in recent outbreaks and unpredictable changes of highly pathogenic avian influenza (HPAI) H5N1 in birds and humans highlights the urgent need to develop a cross-protective H5N1 vaccine. We here report our development of a multiple-clade H5N1 influenza vaccine tested for immunogenicity and efficacy to confer cross-protection in an animal model.<h4>Methodology/principal findings</h4>Mice received two doses of influenza split vaccine with oil-in-water emulsion adjuvant SP01 by intranasal administration separated by two weeks. Single vaccines (3 µg HA per dose) included rg-A/Vietnam/1203/2004(Clade 1), rg-A/Indonesia/05/2005(Clade 2.1), and rg-A/Anhui/1/2005(Clade 2.3.4). The trivalent vaccine contained 1 µg HA per dose of each single vaccine. Importantly, complete cross-protection was observed in mice immunized using trivalent vaccine with oil-in-water emulsion adjuvant SP01 that was subsequently challenged with the lethal A/OT/SZ/097/03 influenza strain (Clade 0), whereas only the survival rate was up to 60% in single A/Anhui/1/2005 vaccine group.<h4>Conclusion/significance</h4>Our findings demonstrated that the multiple-clade H5N1 influenza vaccine was able to elicit a cross-protective immune response to heterologous HPAI H5N1 virus, thus giving rise to a broadly cross-reactive vaccine to potential prevention use ahead of the strain-specific pandemic influenza vaccine in the event of an HPAI H5N1 influenza outbreak. Also, the multiple-clade adjuvanted vaccine could be useful in allowing timely initiation of vaccination against unknown pandemic virus. |
format |
article |
author |
Penghui Yang Yueqiang Duan Peirui Zhang Zhiwei Li Cheng Wang Mei Dong Chong Tang Li Xing Hongjing Gu Zhongpeng Zhao Xiufan Liu Shaogeng Zhang Xiliang Wang |
author_facet |
Penghui Yang Yueqiang Duan Peirui Zhang Zhiwei Li Cheng Wang Mei Dong Chong Tang Li Xing Hongjing Gu Zhongpeng Zhao Xiufan Liu Shaogeng Zhang Xiliang Wang |
author_sort |
Penghui Yang |
title |
Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination. |
title_short |
Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination. |
title_full |
Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination. |
title_fullStr |
Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination. |
title_full_unstemmed |
Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination. |
title_sort |
multiple-clade h5n1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2012 |
url |
https://doaj.org/article/81168c1b49bd4041a4f4db30461827a8 |
work_keys_str_mv |
AT penghuiyang multiplecladeh5n1influenzasplitvaccineelicitsbroadcrossprotectionagainstlethalinfluenzaviruschallengeinmicebyintranasalvaccination AT yueqiangduan multiplecladeh5n1influenzasplitvaccineelicitsbroadcrossprotectionagainstlethalinfluenzaviruschallengeinmicebyintranasalvaccination AT peiruizhang multiplecladeh5n1influenzasplitvaccineelicitsbroadcrossprotectionagainstlethalinfluenzaviruschallengeinmicebyintranasalvaccination AT zhiweili multiplecladeh5n1influenzasplitvaccineelicitsbroadcrossprotectionagainstlethalinfluenzaviruschallengeinmicebyintranasalvaccination AT chengwang multiplecladeh5n1influenzasplitvaccineelicitsbroadcrossprotectionagainstlethalinfluenzaviruschallengeinmicebyintranasalvaccination AT meidong multiplecladeh5n1influenzasplitvaccineelicitsbroadcrossprotectionagainstlethalinfluenzaviruschallengeinmicebyintranasalvaccination AT chongtang multiplecladeh5n1influenzasplitvaccineelicitsbroadcrossprotectionagainstlethalinfluenzaviruschallengeinmicebyintranasalvaccination AT lixing multiplecladeh5n1influenzasplitvaccineelicitsbroadcrossprotectionagainstlethalinfluenzaviruschallengeinmicebyintranasalvaccination AT hongjinggu multiplecladeh5n1influenzasplitvaccineelicitsbroadcrossprotectionagainstlethalinfluenzaviruschallengeinmicebyintranasalvaccination AT zhongpengzhao multiplecladeh5n1influenzasplitvaccineelicitsbroadcrossprotectionagainstlethalinfluenzaviruschallengeinmicebyintranasalvaccination AT xiufanliu multiplecladeh5n1influenzasplitvaccineelicitsbroadcrossprotectionagainstlethalinfluenzaviruschallengeinmicebyintranasalvaccination AT shaogengzhang multiplecladeh5n1influenzasplitvaccineelicitsbroadcrossprotectionagainstlethalinfluenzaviruschallengeinmicebyintranasalvaccination AT xiliangwang multiplecladeh5n1influenzasplitvaccineelicitsbroadcrossprotectionagainstlethalinfluenzaviruschallengeinmicebyintranasalvaccination |
_version_ |
1718423354613956608 |